Monday, Aug 03, 2020 | Last Update : 08:10 PM IST

132nd Day Of Lockdown

Maharashtra44122827680915576 Tamil Nadu2576131964834132 Andhra Pradesh158764828861474 Delhi1376771233174004 Karnataka134819577252496 Uttar Pradesh92921533571730 West Bengal75516527301678 Telangana6766048609551 Gujarat63675466892482 Bihar5727036637322 Rajasthan4441031216706 Assam4290532385105 Haryana3651929690433 Odisha3491321955236 Madhya Pradesh3353523550886 Kerala259121446383 Jammu and Kashmir2141613127396 Punjab1785311466423 Jharkhand121884513115 Chhatisgarh9608699158 Uttarakhand7593443786 Goa6530466853 Tripura5248346323 Puducherry3806230952 Manipur283117377 Himachal Pradesh2654150813 Arunachal Pradesh19359693 Nagaland19356484 Chandigarh111769819 Meghalaya8742645 Sikkim6582891 Mizoram4702580
  Technology   Mobiles & Tabs  16 Jun 2020  How about letting your child play a videogame to help with ADHD?

How about letting your child play a videogame to help with ADHD?

AFP
Published : Jun 16, 2020, 9:20 pm IST
Updated : Jun 16, 2020, 9:20 pm IST

A videogame called EndeavorRx has been approved by the USFDA for children aged 8-12 who have been diagnosed with ADHD.

The USFDA said EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD and is the first game-based therapeutic approved for any type of condition. (Photo | Screengrab)
 The USFDA said EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD and is the first game-based therapeutic approved for any type of condition. (Photo | Screengrab)

Washington: US health officials have approved the first game-based treatment for children with attention deficit hyperactivity disorder, part of a trend toward “digital therapeutics” or software to address certain conditions.

The Food and Drug Administration said Monday it approved the sale by prescription of the game EndeavorRX from health tech startup Akili Interactive for children aged 8-12 who have been diagnosed with ADHD.

 

The FDA said this was the first digital therapeutic intended to treat ADHD, as well as the first game-based therapeutic approved for any type of condition.

The game, designed to improve cognitive function, is designed as part of a programme that may also include other kinds of therapy, medication, and educational programs.

“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren, director of the FDA Center for Devices and Radiological Health.

Digital therapeutics have been approved for certain treatments such as addiction disorders and are being testing for a range of other conditions from chronic pain to anxiety.

 

EndeavorRX allows children to control cartoon-like characters on a type of hoverboard and is designed to target and activate neural systems through sensory stimuli and motor challenges to improve cognitive functioning.

“We’re proud to make history today with FDA’s decision,” said Eddie Martucci, chief executive officer of Akili.

“With EndeavorRx, we’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.”

The approval of EndeavorRx followed studies of some 600 children diagnosed with ADHD.

The company said the research found that after four weeks of EndeavorRx treatment, one-third of children no longer had a measurable attention deficit on at least one measure of objective attention and that about half of parents saw a meaningful change in their child’s day-to-day impairments after one month of treatment with EndeavorRx.

 

Tags: videogames, adhd, usfda